Financial Investors Trust ALPS/CoreCommodity Natural Resources ETF

CCNR

Market cap $399M

Commodities exchange traded fund exposure may matter more now than at any recent point. That was the central message at a VettaFi webcast held Tuesday.

Volatile gold and oil prices are certainly among the reasons why the commodities complex is generating plenty of buzz this year. However, that turbulence isn't altering the fact that commodities, in broad fashion, are performing admirably in 2026.

Due in large part to soaring energy prices, investors holding basic energy sector ETFs are being rewarded this year. However, oil isn't the only commodity setting a torrid pace.

The ALPS CoreCommodity Natural Resources ETF (CCNR) has delivered a 23.86% gain year-to-date, making it the top performer among all ALPS-managed funds as investors position for what Goldman Sachs Asset Management calls a “new resource reality.” Key Takeaways: CCNR posted a 23.86% YTD gain, topping all ALPS funds on natural resource demand.

Artificial intelligence infrastructure investing requires looking beyond semiconductors to the physical systems powering the digital revolution, according to Paul Baiocchi, head of fund strategy at SS&C ALPS Advisors. In an interview at the Exchange conference in Las Vegas, Baiocchi outlined a mosaic approach using three funds to capture different layers of infrastructure growth.

A commodity rally that powered energy and metals higher over the past year may be ready for its next phase, with agriculture taking the lead. The ALPS CoreCommodity Natural Resources ETF (CCNR) returned 18.1% year-to-date through March, making it the top performer across the ALPS fund lineup, according to ETF Database.

Biotech and natural resources funds led the ALPS ETFs lineup in 2025, with both strategies delivering returns above 45%, according to ETF Database. The ALPS Medical Breakthroughs ETF (SBIO) gained just over 57% through December 23, topping all ALPS products for the year, according to ETF Database.

Biotech and natural resources funds led the ALPS ETFs lineup in 2025, with both strategies delivering returns above 45%, according to ETF Database. The ALPS Medical Breakthroughs ETF (SBIO) gained just over 57% through December 23, topping all ALPS products for the year, according to ETF Database.

With higher growth sectors and glitzier commodities soaring, the energy sector isn't getting much attention this year beyond the standard focus on oil market gyrations. That's not to say energy stocks have been “bad” per se, but as highlighted by the S&P Energy Select Sector Index, the group is trailing the broader market.

Artificial intelligence (AI), cloud computing, and machine learning are just a few of the obvious tech innovations dominating the majority of investor attention spans these days. Along with the companies focused on these technologies, attention also diverts to those integral to meeting hardware demands, like semiconductor firms.